Literature DB >> 15287326

Warfarin therapy in older adults: managing treatment in the primary care setting.

Pam Perrin Perrero1, Deborah F Willoughby, Julie A Eggert, Sandra Harley Counts.   

Abstract

Oral anticoagulant therapy with war farin is commonly used to prevent thromboembolic events in patients at risk. The degree of anticoagulation is variable among individuals and is influenced by many factors; therefore, patients must be monitored frequently to assess for potential adverse effects related to treatment. Individuals older than age 65 are at particular risk for thromboembolic events as well as anticoag ulant-related complications. Because of these factors, elderly individuals pose a unique challenge in maintain ing anticoagulant control. The purpose of this article is to revisit the role of warfarin therapy for elderly individ uals in the primary care setting and to provide nurse practitioners with the information necessary to prescribe and monitor this medication appropriately. This article provides indications for warfarin therapy and also identifies potential barriers to effective management with specific implications for the older population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287326     DOI: 10.3928/0098-9134-20040701-09

Source DB:  PubMed          Journal:  J Gerontol Nurs        ISSN: 0098-9134            Impact factor:   1.254


  2 in total

1.  Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics.

Authors:  Jonas Wallvik; Anders Själander; Lars Johansson; Orjan Bjuhr; Jan-Håkan Jansson
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

2.  Standardized warfarin monitoring decreases adverse drug reactions.

Authors:  Lisa B E Shields; Paula Fowler; Diane M Siemens; Douglas J Lorenz; Kenneth C Wilson; Steven T Hester; Joshua T Honaker
Journal:  BMC Fam Pract       Date:  2019-11-07       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.